Precision Medicine and Radiogenomics in Breast Cancer: New Approaches toward Diagnosis and Treatment

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482

Initial sequencing and analysis of the human genome

International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216

Textural Features for Image Classification

Haralick, R. M., Shanmugam, K., & Dinstein, I. (1973) · IEEE Transactions on Systems, Man, and Cybernetics · doi:10.1109/tsmc.1973.4309314 · Cited by 22,886

Molecular portraits of human breast tumours

Perou, C., Sørlie, T., Eisen, M., van de Rijn, M., Jeffrey, S., Rees, C. A., Pollack, J., Ross, D., Johnsen, H., Akslen, L., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,551

Comprehensive molecular portraits of human breast tumours

The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129

Radiomics: Images Are More than Pictures, They Are Data

Gillies, R. J., Kinahan, P. E., & Hricak, H. (2016) · Radiology · doi:10.1148/radiol.2015151169 · Cited by 8,421

Radiomics: extracting more information from medical images using advanced feature analysis

Lambin, P., Rios-Velazquez, E., Leijenaar, R., Carvalho, S., van Stiphout, R. G. P. M., Granton, P., Zegers, C. M. L., Gillies, R., Boellard, R., Dekker, A., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.11.036 · Cited by 6,084

Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

Romond, E. H., Perez, E. A., Bryant, J., Suman, V. J., Geyer, C. E., Davidson, N. E., Tan-Chiu, E., Martino, S., Paik, S., Kaufman, P. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052122 · Cited by 5,438

A New Initiative on Precision Medicine

Collins, F. S., & Varmus, H. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500523 · Cited by 5,202

The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository

Clark, K., Vendt, B., Smith, K., Freymann, J., Kirby, J., Koppel, P., Moore, S., Phillips, S., Maffitt, D., Pringle, M., et al. (2013) · Journal of Digital Imaging · doi:10.1007/s10278-013-9622-7 · Cited by 4,599

Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study

Carey, L., Perou, C. M., Livasy, C., Dressler, L. G., Cowan, D., Conway, K., Karaca, G., Troester, M. A., Tse, C. K., Edmiston, S. N., et al. (2006) · JAMA · doi:10.1001/jama.295.21.2492 · Cited by 3,888

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

Goldhirsch, A., Winer, E. P., Coates, A. S., Gelber, R. D., Piccart, M. J., Thurlimann, B. J. K., Senn, H.-J., Albain, K. S., André, F., Bergh, J. C. S., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt303 · Cited by 3,848

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

Goldhirsch, A., Wood, W. C., Coates, A. S., Gelber, R. D., Thurlimann, B. J. K., & Senn, H.-J. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr304 · Cited by 3,836

International network of cancer genome projects

The International Cancer Genome Consortium (2010) · Nature · doi:10.1038/nature08987 · Cited by 2,299

Radiomics: the process and the challenges

Kumar, V., Gu, Y., Basu, S., Berglund, A., Eschrich, S. A., Schabath, M. B., Forster, K., Aerts, H. J. W. L., Dekker, A., Fenstermacher, D., et al. (2012) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2012.06.010 · Cited by 2,258

Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

Coates, A. S., Winer, E. P., Goldhirsch, A., Gelber, R. D., Gnant, M. I., Piccart, M. J., Thürlimann, B., Senn, H.-J., André, F., Baselga, J. M., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv221 · Cited by 1,862

Identifying differentially expressed genes using false discovery rate controlling procedures

Reiner, A., Yekutieli, D., & Benjamini, Y. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btf877 · Cited by 1,765

The landscape of cancer genes and mutational processes in breast cancer

Stephens, P. J., Tarpey, P. S., Davies, H. R., Loo, P. V., Greenman, C., Wedge, D. C., Nik‐Zainal, S., Martin, S., Varela, I., Bignell, G. R., et al. (2012) · Nature · doi:10.1038/nature11017 · Cited by 1,731

Proteogenomics connects somatic mutations to signalling in breast cancer

CPTAC, N., Mertins, P., Mani, D. R., Ruggles, K. V., Gillette, M. A., Clauser, K. R., Wang, P., Wang, X., Qiao, J. W., Cao, S., et al. (2016) · Nature · doi:10.1038/nature18003 · Cited by 1,676

The Sequence of the Human Genome

Venter, J. C., Smith, H. O., & Adams, M. D. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.237016 · Cited by 1,665

The molecular portraits of breast tumors are conserved across microarray platforms

Hu, Z., Fan, C., Oh, D. S., Marron, J. S., He, X., Qaqish, B. F., Livasy, C., Carey, L., Reynolds, E. R., Dressler, L. G., et al. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-96 · Cited by 1,587

Targeting cancer metabolism: a therapeutic window opens

Heiden, M. G. V. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3504 · Cited by 1,443

Transcriptomics technologies

Lowe, R. G. T., Shirley, N. J., Bleackley, M. R., Dolan, S., & Shafee, T. M. A. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005457 · Cited by 1,307

Methods of integrating data to uncover genotype-phenotype interactions

Ritchie, M. D., Holzinger, E. R., Li, R., Pendergrass, S. A., & Kim, D. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3868 · Cited by 1,085

Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer

Haffty, B. G., Yang, Q., Reiß, M., Kearney, T. J., Higgins, S. A., Weidhaas, J. B., Harris, L. N., Hait, W., & Toppmeyer, D. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.5664 · Cited by 1,085

MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype

Blenkiron, C., Goldstein, L. D., Thorne, N., Spiteri, I., Chin, S., Dunning, M., Barbosa‐Morais, N. L., Teschendorff, A. E., Green, A. R., Ellis, I. O., et al. (2007) · Genome biology · doi:10.1186/gb-2007-8-10-r214 · Cited by 974

MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer

Bertoli, G. R., Cava, C., & Castiglioni, I. (2015) · Theranostics · doi:10.7150/thno.11543 · Cited by 836

Subclonal diversification of primary breast cancer revealed by multiregion sequencing

Yates, L. R., Gerstung, M., Knappskog, S., Desmedt, C., Gundem, G., Loo, P. V., Aas, T., Alexandrov, L. B., Larsimont, D., Davies, H., et al. (2015) · Nature Medicine · doi:10.1038/nm.3886 · Cited by 833

What is next generation sequencing?

Behjati, S., & Tarpey, P. S. (2013) · Archives of Disease in Childhood Education & Practice · doi:10.1136/archdischild-2013-304340 · Cited by 829

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Harris, L. N., Ismaila, N., McShane, L. M., André, F., Collyar, D. E., Gonzalez-Angulo, A. M., Hammond, E. H., Kuderer, N. M., Liu, M., Mennel, R. G., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.2289 · Cited by 812

Gene expression profiling in breast cancer: classification, prognostication, and prediction

Reis-Filho, J. S., & Pusztai, L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61539-0 · Cited by 741

Systems Biology, Proteomics, and the Future of Health Care: Toward Predictive, Preventative, and Personalized Medicine

Weston, A. D., & Hood, L. (2004) · Journal of Proteome Research · doi:10.1021/pr0499693 · Cited by 738

MaZda—A software package for image texture analysis

Szczypiński, P. M., Strzelecki, M., Materka, A., & Klepaczko, A. (2008) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2008.08.005 · Cited by 712

Visualization of omics data for systems biology

Gehlenborg, N., O’Donoghue, S. I., Baliga, N. S., Goesmann, A., Hibbs, M., Kitano, H., Kohlbacher, O., Neuweger, H., Schneider, R., Tenenbaum, D., et al. (2010) · Nature Methods · doi:10.1038/nmeth.1436 · Cited by 629

From big data analysis to personalized medicine for all: challenges and opportunities

Alyass, A., Turcotte, M., & Meyre, D. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0108-y · Cited by 575

The evolution of molecular biology into systems biology

Westerhoff, H. V., & Palsson, B. Ø. (2004) · Nature Biotechnology · doi:10.1038/nbt1020 · Cited by 573

Here is the evidence, now what is the hypothesis? The complementary roles of inductive and hypothesis‐driven science in the post‐genomic era

Kell, D. B., & Oliver, S. G. (2004) · BioEssays · doi:10.1002/bies.10385 · Cited by 535

An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer

Teschendorff, A. E., Miremadi, A., Pinder, S. E., Ellis, I. O., & Caldas, C. (2007) · Genome biology · doi:10.1186/gb-2007-8-8-r157 · Cited by 502

The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade

Weigelt, B., Baehner, F. L., & Reis-Filho, J. S. (2009) · The Journal of Pathology · doi:10.1002/path.2648 · Cited by 500

MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays

Li, H., Zhu, Y., Burnside, E. S., Drukker, K., Hoadley, K. A., Fan, C., Conzen, S. D., Whitman, G. J., Sutton, E. J., Net, J., et al. (2016) · Radiology · doi:10.1148/radiol.2016152110 · Cited by 475

Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging

Sala, E., Mema, E., Himoto, Y., Veeraraghavan, H., Brenton, J. D., Snyder, A., Weigelt, B., & Vargas, H. A. (2016) · Clinical Radiology · doi:10.1016/j.crad.2016.09.013 · Cited by 369

Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data set

Li, H., Zhu, Y., Burnside, E. S., Huang, E. P., Drukker, K., Hoadley, K. A., Fan, C., Conzen, S. D., Zuley, M. L., Net, J., et al. (2016) · npj Breast Cancer · doi:10.1038/npjbcancer.2016.12 · Cited by 363

Patterns of Recurrence and Outcome According to Breast Cancer Subtypes in Lymph Node–Negative Disease: Results From International Breast Cancer Study Group Trials VIII and IX

Metzger, O., Sun, Z., Viale, G., Price, K. N., Crivellari, D., Snyder, R. D., Gelber, R. D., Castiglione‐Gertsch, M., Coates, A. S., Goldhirsch, A., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.1574 · Cited by 344

A Decade of Systems Biology

Chuang, H., Hofree, M., & Ideker, T. (2010) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100109-104122 · Cited by 327

A Review of Applications of Metabolomics in Cancer

Beger, R. D. (2013) · Metabolites · doi:10.3390/metabo3030552 · Cited by 300

Triple-Modality Screening Trial for Familial Breast Cancer Underlines the Importance of Magnetic Resonance Imaging and Questions the Role of Mammography and Ultrasound Regardless of Patient Mutation Status, Age, and Breast Density

Riedl, C. C., Luft, N., Bernhart, C., Weber, M., Bernathova, M., Tea, M.-K. M., Rudas, M., Singer, C. F., & Helbich, T. H. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.8626 · Cited by 299

Transcriptome Profiling in Human Diseases: New Advances and Perspectives

Casamassimi, A., Federico, A., Rienzo, M., Esposito, S., & Ciccodicola, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081652 · Cited by 297

Radiogenomics: What It Is and Why It Is Important

Mazurowski, M. A. (2015) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2015.04.019 · Cited by 292

Next-generation sequencing

Reis-Filho, J. S. (2009) · Breast Cancer Research · doi:10.1186/bcr2431 · Cited by 284

Serum Circulating microRNA Profiling for Identification of Potential Breast Cancer Biomarkers

Mar‐Aguilar, F., Mendoza-Ramírez, J. A., Malagón‐Santiago, G. I., Espino-Silva, P. K., Santuario-Facio, S. K., Ruíz-Flores, P., Rodrı́guez-Padilla, C., & Reséndez‐Pérez, D. (2013) · Disease Markers · doi:10.1155/2013/259454 · Cited by 280

Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes

Rodríguez, M., Bajo-Santos, C., Hessvik, N. P., Lorenz, S., Fromm, B., Berge, V., Sandvig, K., Linē, A., & Llorente, A. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0726-4 · Cited by 255

The topography of mutational processes in breast cancer genomes

Morganella, S., Alexandrov, L. B., Głodzik, D., Zou, X., Davies, H. R., Staaf, J., Sieuwerts, A. M., Brinkman, A. B., Martin, S., Ramakrishna, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms11383 · Cited by 252

Behind the Numbers: Decoding Molecular Phenotypes with Radiogenomics—Guiding Principles and Technical Considerations

Kuo, M. D., & Jamshidi, N. (2014) · Radiology · doi:10.1148/radiol.13132195 · Cited by 238

PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell signaling to clinical trials

Dey, N., De, P. K., & Leyland-Jones, B. R. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.037 · Cited by 237

Radiogenomic Analysis of Breast Cancer: Luminal B Molecular Subtype Is Associated with Enhancement Dynamics at MR Imaging

Mazurowski, M. A., Zhang, J., Grimm, L. J., Yoon, S. C., & Silber, J. I. (2014) · Radiology · doi:10.1148/radiol.14132641 · Cited by 237

Identification of prostate cancer biomarkers in urinary exosomes

Øverbye, A., Skotland, T., Koehler, C. J., Thiede, B., Seierstad, T., Berge, V., Sandvig, K., & Llorente, A. (2015) · Oncotarget · doi:10.18632/oncotarget.4851 · Cited by 231

Mapping the Cancer Genome

Collins, F. S., & Barker, A. D. (2007) · Scientific American · doi:10.1038/scientificamerican0307-50 · Cited by 231

Penetrance estimates for BRCA1 and BRCA2based on genetic testing in a Clinical Cancer Genetics service setting: Risks of breast/ovarian cancer quoted should reflect the cancer burden in the family

Evans, D. G., Shenton, A., Woodward, E. R., Lalloo, F. I., Howell, A., & Maher, E. R. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-155 · Cited by 224

Magnetic resonance imaging texture analysis classification of primary breast cancer

Waugh, S. A., Purdie, C. A., Jordan, L. B., Vinnicombe, S., Lerski, R. A., Martin, P., & Thompson, A. M. (2015) · European Radiology · doi:10.1007/s00330-015-3845-6 · Cited by 203

Big Data and Biomedical Informatics: A Challenging Opportunity

Bellazzi, R. (2014) · Yearbook of Medical Informatics · doi:10.15265/iy-2014-0024 · Cited by 184

Medical imaging in personalised medicine: a white paper of the research committee of the European Society of Radiology (ESR)

European Society of Radiology (ESR) (2015) · Insights into Imaging · doi:10.1007/s13244-015-0394-0 · Cited by 178

Mapping the cancer genome. Pinpointing the genes involved in cancer will help chart a new course across the complex landscape of human malignancies.

Collins, F. S., & Barker, A. D. (2007) · PubMed · Cited by 176

Cancer Metabolism and Drug Resistance

Rahman, M., & Hasan, M. R. (2015) · Metabolites · doi:10.3390/metabo5040571 · Cited by 175

St. Gallen 2013: Brief Preliminary Summary of the Consensus Discussion

Harbeck, N., Thomssen, C., & Gnant, M. (2013) · Breast Care · doi:10.1159/000351193 · Cited by 174

Breast Cancer Adjuvant Therapy: Time to Consider Its Time-Dependent Effects

Jatoi, I., Anderson, W. F., Jeong, J., & Redmond, C. K. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.3550 · Cited by 172

Radiogenomic Analysis of Breast Cancer Using MRI: A Preliminary Study to Define the Landscape

Yamamoto, S., Maki, D. D., Korn, R. L., & Kuo, M. (2012) · American Journal of Roentgenology · doi:10.2214/ajr.11.7824 · Cited by 172

Human genomics projects and precision medicine

Carrasco-Ramiro, F., Peiró‐Pastor, R., & Aguado, B. (2017) · Gene Therapy · doi:10.1038/gt.2017.77 · Cited by 169

Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma

Reuben, A., Spencer, C. N., Prieto, P. A., Gopalakrishnan, V., Reddy, S. M., Miller, J. P., Mao, X., De Macedo, M. P., Chen, J., Song, X., et al. (2017) · npj Genomic Medicine · doi:10.1038/s41525-017-0013-8 · Cited by 166

Deciphering Genomic Underpinnings of Quantitative MRI-based Radiomic Phenotypes of Invasive Breast Carcinoma

Zhu, Y., Li, H., Guo, W., Drukker, K., Lan, L., Giger, M. L., & Ji, Y. (2015) · Scientific Reports · doi:10.1038/srep17787 · Cited by 165

Breast cancer classification by proteomic technologies: Current state of knowledge

Lam, S. W., Jiménez, C. R., & Boven, E. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.06.006 · Cited by 162

Computational approach to radiogenomics of breast cancer: Luminal A and luminal B molecular subtypes are associated with imaging features on routine breast MRI extracted using computer vision algorithms

Grimm, L. J., Zhang, J., & Mazurowski, M. A. (2015) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24879 · Cited by 153

Methods, Tools and Current Perspectives in Proteogenomics

Ruggles, K. V., Krug, K., Wang, X., Clauser, K. R., Wang, J., Payne, S., Fenyö, D., Zhang, B., & Mani, D. R. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.mr117.000024 · Cited by 152

Identification of Intrinsic Imaging Phenotypes for Breast Cancer Tumors: Preliminary Associations with Gene Expression Profiles

Ashraf, A. B., Daye, D., Gavenonis, S. C., Mies, C., Feldman, M. D., Rosen, M. A., & Despina Kontos, B. (2014) · Radiology · doi:10.1148/radiol.14131375 · Cited by 152

New frontiers in metabolomics: from measurement to insight

Riekeberg, E., & Powers, R. (2017) · F1000Research · doi:10.12688/f1000research.11495.1 · Cited by 149

Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer

Volinia, S., & Croce, C. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304977110 · Cited by 149

Magnetic resonance image–guided proteomics of human glioblastoma multiforme

Hobbs, S. K., Shi, G., Homer, R., Harsh, G., Atlas, S. W., & Bednarski, M. D. (2003) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10395 · Cited by 139

Breast cancer subtype intertumor heterogeneity: MRI‐based features predict results of a genomic assay

Sutton, E. J., Oh, J. H., Dashevsky, B. Z., Veeraraghavan, H., Apte, A., Thakur, S. B., Deasy, J. O., & Morris, E. A. (2015) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24890 · Cited by 138

Breast cancer molecular subtype classifier that incorporates MRI features

Sutton, E. J., Dashevsky, B. Z., Oh, J. H., Veeraraghavan, H., Apte, A., Thakur, S. B., Morris, E. A., & Deasy, J. O. (2016) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25119 · Cited by 138

Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine

Kamel, H. F. M., & Al-Amodi, H. S. A. B. (2017) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2016.11.005 · Cited by 137

Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer

Kim, Y., Jeon, J., Mejia, S., Yao, C. Q., Ignatchenko, V., Nyalwidhe, J. O., Gramolini, A. O., Lance, R. S., Troyer, D. A., Drake, R. R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11906 · Cited by 126

Breast Cancer Molecular Subtypes in Patients With Locally Advanced Disease: Impact on Prognosis, Patterns of Recurrence, and Response to Therapy

Huber, K. E., Carey, L., & Wazer, D. E. (2009) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2009.05.004 · Cited by 122

Breast Cancer: Radiogenomic Biomarker Reveals Associations among Dynamic Contrast-enhanced MR Imaging, Long Noncoding RNA, and Metastasis

Yamamoto, S., Han, W., Kim, Y., Du, L., Jamshidi, N., Huang, D., Kim, J. H., & Kuo, M. (2015) · Radiology · doi:10.1148/radiol.15142698 · Cited by 120

Predicting long‐term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling

Cao, M. D., Sitter, B., Bathen, T. F., Bofin, A. M., Lønning, P. E., Lundgren, S., & Gribbestad, I. S. (2011) · NMR in Biomedicine · doi:10.1002/nbm.1762 · Cited by 120

An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer

Ruggles, K. V., Tang, Z., Wang, X., Grover, H., Askenazi, M., Teubl, J., Cao, S., McLellan, M. D., Clauser, K. R., Tabb, D. L., et al. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.056226 · Cited by 117

Imaging genomics in cancer research: limitations and promises

Bai, H. X., Lee, A. M., Yang, L., Zhang, P. J., Davatzikos, C. A., Maris, J. M., & Diskin, S. J. (2016) · British Journal of Radiology · doi:10.1259/bjr.20151030 · Cited by 114

Texture analysis methodologies for magnetic resonance imaging

Materka, A. (2004) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2004.6.2/amaterka · Cited by 112

Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer

Chung, L., Moore, K., Phillips, L., Boyle, F. M., Marsh, D. J., & Baxter, R. C. (2014) · Breast Cancer Research · doi:10.1186/bcr3676 · Cited by 108

Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer

Gonzalez-Angulo, A. M., Hennessy, B. T., Meric‐Bernstam, F., Şahin, A. A., Liu, W., Ju, Z., Carey, M. S., Myhre, S., Speers, C. W., Deng, L., et al. (2011) · Clinical Proteomics · doi:10.1186/1559-0275-8-11 · Cited by 102

Novel Applications of Metabolomics in Personalized Medicine: A Mini-Review

Li, B.-B., He, X., Jia, W., & Li, H. (2017) · Molecules · doi:10.3390/molecules22071173 · Cited by 94

Immunotherapy Combined or Sequenced With Targeted Therapy in the Treatment of Solid Tumors: Current Perspectives

Atkins, M. B., & Larkin, J. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv414 · Cited by 92

Target Inhibition Networks: Predicting Selective Combinations of Druggable Targets to Block Cancer Survival Pathways

Tang, J. P., Karhinen, L., Xu, T., Szwajda, A., Yadav, B., Wennerberg, K., & Aittokallio, T. A. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003226 · Cited by 91

Improved Differentiation of Benign and Malignant Breast Tumors with Multiparametric 18Fluorodeoxyglucose Positron Emission Tomography Magnetic Resonance Imaging: A Feasibility Study

Pinker, K., Bogner, W., Baltzer, P., Karanikas, G., Magometschnigg, H. F., Brader, P., Gruber, S., Bickel, H., Dubsky, P. C., Bagó-Horváth, Z., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2810 · Cited by 87

Quantitative Sodium MR Imaging at 7 T: Initial Results and Comparison with Diffusion-weighted Imaging in Patients with Breast Tumors

Zaric, O., Pinker, K., Zbýň, Š., Strasser, B., Robinson, S., Minarikova, L., Gruber, S., Farr, A., Singer, C., Helbich, T. H., et al. (2016) · Radiology · doi:10.1148/radiol.2016151304 · Cited by 86

Comprehensive proteomics

Beck, M., Claassen, M., & Aebersold, R. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2010.09.002 · Cited by 83

Metabolomics Biomarkers for Breast Cancer

Günther, U. L. (2015) · Pathobiology · doi:10.1159/000430844 · Cited by 80

Qualitative Radiogenomics: Association between Oncotype DX Test Recurrence Score and BI-RADS Mammographic and Breast MR Imaging Features

Woodard, G. A., Ray, K. M., Joe, B. N., & Price, E. R. (2017) · Radiology · doi:10.1148/radiol.2017162333 · Cited by 77

Cancer detection and biopsy classification using concurrent histopathological and metabolomic analysis of core biopsies

Brown, M. V., McDunn, J. E., Gunst, P. R., Smith, E. M., Milburn, M. V., Troyer, D. A., & Lawton, K. A. (2012) · Genome Medicine · doi:10.1186/gm332 · Cited by 73

Precision medicine and molecular imaging: new targeted approaches toward cancer therapeutic and diagnosis.

Ghasemi, M., Nabipour, I., Omrani, A., Alipour, Z., & Assadi, M. (2016) · PubMed Central · Cited by 72

MRI phenotype of breast cancer: Kinetic assessment for molecular subtypes

Blaschke, E. M., & Abé, H. (2015) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24884 · Cited by 71

Precision medicine in breast cancer: reality or utopia?

Bettaı̈eb, A., Paul, C., Plenchette, S., Shan, J., Chouchane, L., & Ghiringhelli, F. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1239-z · Cited by 69

White paper on imaging biomarkers

European Society of Radiology (ESR) (2010) · Insights into Imaging · doi:10.1007/s13244-010-0025-8 · Cited by 67

Current FDA-approved treatments for non-small cell lung cancer and potential biomarkers for its detection

Ruiz-Ceja, K. A., & Chirino, Y. I. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.03.018 · Cited by 66

Molecular signatures in breast cancer

Lal, S., Reed, A. E. M., Luca, X. M. D., & Simpson, P. T. (2017) · Methods · doi:10.1016/j.ymeth.2017.06.032 · Cited by 65

Many Phenotypes Without Many False Discoveries: Error Controlling Strategies for Multitrait Association Studies

Peterson, C. B., Bogomolov, M., Benjamini, Y., & Sabatti, C. (2015) · Genetic Epidemiology · doi:10.1002/gepi.21942 · Cited by 64

Intratumoral heterogeneity of the distribution of kinetic parameters in breast cancer: comparison based on the molecular subtypes of invasive breast cancer

Yamaguchi, K., Abé, H., Newstead, G. M., Egashira, R., Nakazono, T., Imaizumi, T., & Irié, H. (2014) · Breast Cancer · doi:10.1007/s12282-013-0512-0 · Cited by 63

Pharmacokinetic Tumor Heterogeneity as a Prognostic Biomarker for Classifying Breast Cancer Recurrence Risk

Mahrooghy, M., Ashraf, A. B., Daye, D., McDonald, E. S., Rosen, M. A., Mies, C., Feldman, M. D., & Despina Kontos, B. (2015) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2015.2395812 · Cited by 62

How could breast cancer molecular features contribute to locoregional treatment decision making?

Tsoutsou, P. P., Vozenin, M., Durham, A., & Bourhis, J. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.12.006 · Cited by 62

Imaging in the Age of Precision Medicine: Summary of the Proceedings of the 10th Biannual Symposium of the International Society for Strategic Studies in Radiology

Herold, C., Lewin, J. S., Wibmer, A. G., Thrall, J. H., Krestin, G. P., Dixon, A. K., Schoenberg, S. O., Geckle, R. J., Muellner, A., & Hricak, H. (2015) · Radiology · doi:10.1148/radiol.2015150709 · Cited by 61

Cholangiocarcinoma: Correlation between Molecular Profiling and Imaging Phenotypes

Sadot, E., Simpson, A. L., Gian, R. K., Gönen, M., Shia, J., Allen, P. J., D'Angelica, M. I., DeMatteo, R. P., Kingham, T. P., & Jarnagin, W. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132953 · Cited by 59

Big Data: the challenge for small research groups in the era of cancer genomics

Noor, A. M., Holmberg, L., Gillett, C., & Grigoriadis, A. E. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.341 · Cited by 59

Breast MRI radiogenomics: Current status and research implications

Grimm, L. J. (2015) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25116 · Cited by 53

Translating cancer epigenomics into the clinic: focus on lung cancer

Marí‐Alexandre, J., Díaz‐Lagares, Á., Villalba-Esparza, M., Juan, Ó., Crujeiras, A. B., Calvo, A., & Sandoval, J. (2017) · Translational research · doi:10.1016/j.trsl.2017.05.008 · Cited by 51

Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer

Al‐Ejeh, F., Miranda, M. S., Shi, W., Simpson, P. T., Song, S., Vargas, A. C., Saunus, J. M., Smart, C. E., Mariasegaram, M., Wiegmans, A. P., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1865 · Cited by 48

A New Contrast in MR Mammography by Means of Chemical Exchange Saturation Transfer (CEST) Imaging at 3 Tesla: Preliminary Results

Schmitt, B., Zámecnik, P., Zaiß, M., Rerich, E., Schuster, L., Bachert, P., & Schlemmer, H. (2011) · RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · doi:10.1055/s-0031-1281764 · Cited by 47

Detecting blood oxygen level‐dependent (BOLD) contrast in the breast

Rakow‐Penner, R., Daniel, B. L., & Glover, G. H. (2010) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22227 · Cited by 46

Relationships Between MRI Breast Imaging-Reporting and Data System (BI-RADS) Lexicon Descriptors and Breast Cancer Molecular Subtypes: Internal Enhancement is Associated with Luminal B Subtype

Grimm, L. J., Zhang, J., Baker, J. A., Soo, M. S., Johnson, K. S., & Mazurowski, M. A. (2017) · The Breast Journal · doi:10.1111/tbj.12799 · Cited by 46

Next-Generation Proteomics and Its Application to Clinical Breast Cancer Research

Mardamshina, M., & Geiger, T. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.07.003 · Cited by 45

Mutation matters in precision medicine: A future to believe in

Dey, N., Williams, C. B., Leyland-Jones, B. R., & De, P. K. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.03.002 · Cited by 41

Qualitative Age Interactions in Breast Cancer Studies: Mind the Gap

Anderson, W. F., Jatoi, I., & Sherman, M. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.9450 · Cited by 40

Personalized Medicine in the U.S. and Germany: Awareness, Acceptance, Use and Preconditions for the Wide Implementation into the Medical Standard

Kichko, K., Marschall, P., & Flessa, S. (2016) · Journal of Personalized Medicine · doi:10.3390/jpm6020015 · Cited by 36

Introduction of an Automated User–Independent Quantitative Volumetric Magnetic Resonance Imaging Breast Density Measurement System Using the Dixon Sequence

Wengert, G., Helbich, T. H., Vogl, W., Baltzer, P., Langs, G., Weber, M., Bogner, W., Gruber, S., Trattnig, S., & Pinker, K. (2014) · Investigative Radiology · doi:10.1097/rli.0000000000000102 · Cited by 34

Opportunities for Nanotechnology-Based Innovation in Tissue Proteomics

Geho, D. H., Lahar, N., Mauro Ferrari, B., Petricoin, E. F., & Liotta, L. A. (2004) · Biomedical Microdevices · doi:10.1023/b:bmmd.0000042053.51016.b4 · Cited by 32

Moreton Lecture: Imaging in the Age of Precision Medicine

Thrall, J. H. (2015) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2015.06.003 · Cited by 28

Gene-Expression-Based Predictors for Breast Cancer

Gupta, A., Mutebi, M. C., & Bardia, A. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4703-0 · Cited by 28

Prognostic and predictive biomarkers in melanoma: an update

Foth, M., Wouters, J., de Chaumont, C., Dynoodt, P., & Gallagher, W. M. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2016.1126511 · Cited by 25

The Evolving Role of Companion Diagnostics for Breast Cancer in an Era of Next-Generation Omics

Rosenbaum, J. N., & Weisman, P. S. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.04.021 · Cited by 22

Genomic profiling of breast cancers

Curtis, C. N. (2014) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000145 · Cited by 21

‘Omics Approaches in Breast Cancer Research and Clinical Practice

Croft, P. K., Al‐Ejeh, F., Reed, A. E. M., Saunus, J. M., & Lakhani, S. R. (2016) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000128 · Cited by 20

Optimizing targeted cancer therapy: Towards clinical application of systems biology approaches

Sikkema, A. H., den Dunnen, W. F. A., Diks, S. H., Peppelenbosch, M. P., & de Bont, E. S. J. M. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.05.002 · Cited by 19

CEST-imaging: A new contrast in MR-mammography by means of chemical exchange saturation transfer

Schmitt, B., Trattnig, S., & Schlemmer, H.-P. (2012) · European Journal of Radiology · doi:10.1016/s0720-048x(12)70060-8 · Cited by 18

Metabolomics and Cardiology: Toward the Path of Perinatal Programming and Personalized Medicine

Pintus, R., Bassareo, P. P., Dessì, A., Deidda, M., Mercuro, G. G., & Fanos, V. (2017) · BioMed Research International · doi:10.1155/2017/6970631 · Cited by 17

Transcriptomics Using Next Generation Sequencing Technologies

Lee‐Liu, D., Almonacid, L. I., Faunes, F., Melo, F., & Larraı́n, J. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-992-1_18 · Cited by 16

Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?

Chung, C., & Ma, H. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1977 · Cited by 16

Precision Military Medicine: Conducting a multi-site clinical utility study of genomic and lifestyle risk factors in the United States Air Force

Delaney, S., Brenner, R., Schmidlen, T., Dempsey, M. P., London, K. E., Gordon, E. S., Bellafante, M., Nasuti, A., Scheinfeldt, L., Rajula, K. D., et al. (2017) · npj Genomic Medicine · doi:10.1038/s41525-016-0004-1 · Cited by 14

Immunotherapy in glioblastoma: emerging options in precision medicine

Hodges, T. R., Ferguson, S. D., & Heimberger, A. B. (2016) · CNS Oncology · doi:10.2217/cns-2016-0009 · Cited by 12

A decade of Systems Biology: where are we and where are we going to?

Peitsch, M. C., & de Graaf, D. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.06.002 · Cited by 11

HER2-Orientated Therapy in Early and Metastatic Breast Cancer

Iborra, S., & Stickeler, E. (2016) · Breast Care · doi:10.1159/000453603 · Cited by 11

Radiogenomics and Radioproteomics

Djekidel, M. (2012) · OMICS Journal of Radiology · doi:10.4172/2167-7964.1000115 · Cited by 7

Characterization of enzymatic micromachining for construction of variable cross-section microchannel topologies

Huang, J., Han, D., Ruggles, M., Jayaraman, A., & Ugaz, V. M. (2016) · Biomicrofluidics · doi:10.1063/1.4948508 · Cited by 4

Meeting Report: EMBL Conference – Omics and Personalized Medicine

Peng, J. (2012) · Biotechnology Journal · doi:10.1002/biot.201200122 · Cited by 2

Secure, privacy-preserving and federated machine learning in medical imaging

Kaissis, G. A., Makowski, M. R., Rückert, D., & Braren, R. F. (2020) · Nature Machine Intelligence · doi:10.1038/s42256-020-0186-1 · Cited by 1,676

Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer

Zheng, X., Yao, Z., Huang, Y., Yu, Y., Wang, Y., Liu, Y., Mao, R., Li, F., Xiao, Y., Wang, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15027-z · Cited by 607

Multimodal data fusion for cancer biomarker discovery with deep learning

Steyaert, S., Pizurica, M., Nagaraj, D., Khandelwal, P., Hernandez-Boussard, T., Gentles, A. J., & Gevaert, O. (2023) · Nature Machine Intelligence · doi:10.1038/s42256-023-00633-5 · Cited by 402

Biobanking in health care: evolution and future directions

Coppola, L., Cianflone, A., Grimaldi, A., Incoronato, M., Bevilacqua, P., Messina, F., Baselice, S., Soricelli, A., Mirabelli, P., & Salvatore, M. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1922-3 · Cited by 429

Artificial Intelligence for Mammography and Digital Breast Tomosynthesis: Current Concepts and Future Perspectives

Geras, K. J., Mann, R. M., & Moy, L. P. (2019) · Radiology · doi:10.1148/radiol.2019182627 · Cited by 304

Radiogenomics: a key component of precision cancer medicine

Liu, Z.-Q., Duan, T., Zhang, Y.-Y., Weng, S.-Y., Xu, H.-X., Ren, Y.-Q., Zhang, Z.-Y., & Han, X.-W. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02317-8 · Cited by 98

Radiogenomics in breast cancer: a review

Гаранина, А. Е., & Васильевич, Х. А. (2024) · Diagnostic radiology and radiotherapy · doi:10.22328/2079-5343-2024-15-1-15-21 · Cited by 1

Radiogenomics: bridging the gap between imaging and genomics for precision oncology

He, W., Huang, W., Zhang, L., Wu, X., Zhang, S., & Zhang, B. (2024) · MedComm · doi:10.1002/mco2.722 · Cited by 64

Progress on radiomics and radiogenomics and their applications in breast cancer: A survey

(2023) · Data Science and Informetrics · doi:10.59494/dsi.2023.4.6 · Cited by 1

Combining molecular and imaging metrics in cancer: radiogenomics

Gullo, R. L., Naranjo, I. D., Morris, E. A., & Pinker, K. (2020) · Insights into Imaging · doi:10.1186/s13244-019-0795-6 · Cited by 183